During the talk, we explored the transformative potential of bringing CAR-T to underserved regions, overcoming the unique challenges in low- and middle-income countries. From developing scalable, decentralized manufacturing models to navigating regulatory pathways and ensuring equitable access, the conversation highlighted the pivotal role innovation and collaboration will play in extending these life-saving therapies to all.

This is just the beginning of an important journey to make advanced therapies accessible on a global scale!

Speakers:
– Dr. Boro Dropulić, Executive Director and Co-founder, Caring Cross z
– Kevin Kyle, CEO, Germfree Laboratories
– Jenni Cardamone, Vice President, Partnerships, Devex